NCT05964660

Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias

New 3D-echocardiography-based Motion Integration and mAnagement for subsTrate characteRisation and Stereotactic Arrhythmia radIoablation tX in Ventricular Tachycardias- the MATRIX-VT Study
University of Luebeck·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Ventricular Arrythmia
Study type
Observational
Sponsor & location
Primary sponsor
University of Luebeck
Location
Luebeck, Germany
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Jun 01, 2024
Enrollment
20 participants
Primary outcome

Feasibility of algorithm training to achieve improved arrhythmogenic substrate characterization,Feasibility of algorithm training to improve the planning target volume definition for stereotactic arrhythmia radioablation therapy

Summary

Prospective, observational, single center, pilot study to analyze the feasibility of motion
 and structural data integration in patients with ventricular arrhythmia by means of
 artificial intelligence for improved arrhythmogenic substrate characterization and motion
 management during stereotactic arrhythmia radioablation.

ICD-10 classifications
Ventricular tachycardiaLeft ventricular failureVentricular septal defectCardiomyopathy, unspecifiedCardiac arrhythmia, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05964660
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05964660 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Luebeck and is currently Not yet recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.